The Frazer Institute’s Dermatology Research Centre is internationally recognised for advancing skin cancer research through artificial intelligence, imaging, genomics and teledermatology.
Researchers have pioneered:
- AI tools for melanoma and keratinocyte cancer detection
- automated naevus counting
- assessment of UV-induced skin damage, and
- risk prediction using 3D total-body imaging.
The Centre has also made significant contributions to skin biology, inflammatory skin disease, regenerative medicine and organoid research, improving understanding of skin development, repair, immune responses and disease mechanisms.
Supported by large-scale datasets such as ACEMID, extensive clinical networks, and a strong track record in investigator-led and industry-sponsored clinical trials, the Centre integrates fundamental discovery science with translational and implementation research to improve diagnostic accuracy, expand access to specialist care, and accelerate the safe adoption of innovative technologies in dermatology.